Sonnet BioTherapeutics Holdings, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q4 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $158K.
  • Sonnet BioTherapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2019 was $73.7K.
  • Sonnet BioTherapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2018 was -$701K, a 8.81% decline from 2017.
  • Sonnet BioTherapeutics Holdings, Inc. annual Income Tax Expense (Benefit) for 2017 was -$644K, a 425% decline from 2016.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $158K Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-13
Q1 2020 $19.5K -$3.68K -$54.3K -107% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-18
Q4 2019 $73.7K $12.5K -$65.6K -84% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-19
Q3 2019 $139K $4.8K +$211K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 -$71.8K $5.83K +$243K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 -$314K $50.6K +$387K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 -$701K $78.1K +$892K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$1.59M -$206K -$262K -468% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.33M -$237K -$346K -316% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$984K -$336K -$340K -8954% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$644K -$814K -$874K -1443% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $230K $56.1K +$3.6K +6.85% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $226K $110K +$58.1K +113% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $168K $3.8K -$30.2K -88.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $198K $60.6K -$155K -71.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $353K $52.5K +$39.5K +305% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $314K $51.4K +$59.2K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $254K $34K +$66.9K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $188K $215K +$643K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$456K $13K +$32.7K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$489K -$7.78K +$11.9K +60.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$501K -$32.9K -$24K -270% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$477K -$428K -$442K -3221% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-31
Q3 2014 -$34.6K -$19.7K -$25.7K -428% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-14
Q2 2014 -$8.88K -$19.7K -$31.8K -263% Apr 1, 2014 Jun 30, 2014 10-Q 2015-11-16
Q1 2014 $23K -$8.89K -$18K -198% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-20
Q4 2013 $40.9K $13.7K +$2.51K +22.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 $38.4K $6.02K -$1.98K -24.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $40.4K $12.1K +$12.1K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $28.3K $9.09K +$9.09K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $19.2K $11.2K +$11.2K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $8K $8K +$8K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 $0 $0 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $0 $0 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $0 $0 Oct 1, 2011 Dec 31, 2011 10-K 2013-04-03
Q3 2011 $0 $0 Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 $0 $0 Apr 1, 2011 Jun 30, 2011 10-Q/A 2013-01-02
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-12-28
Q3 2010 $0 Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.